AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations

Cell

Volumn 135, Issue 6, 2008, Pages 1028-1038

  Robbiani, Davide F ^a   Bothmer, Anne ^a   Callen, Elsa ^b   Reina San Martin, Bernardo ^a   Dorsett, Yair ^a   Difilippantonio, Simone ^b   Bolland, Daniel J ^c   Chen, Hua Tang ^b   Corcoran, Anne E ^c   Nussenzweig, André ^b   Nussenzweig, Michel C ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

CELLBIO; HUMDISEASE; MOLIMMUNO

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN HEAVY CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA DAMAGE; MOUSE; NONHUMAN; ONCOGENE C MYC; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOMATIC MUTATION;

MUS;

EID: 57149146036     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2008.09.062     Document Type: Article

References (77)

1. Adams J.M., Gerondakis S., Webb E., Mitchell J., Bernard O., and Cory S. Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. Proc. Natl. Acad. Sci. USA 79 (1982) 6966-6970
2. Adams J.M., Gerondakis S., Webb E., Corcoran L.M., and Cory S. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc. Natl. Acad. Sci. USA 80 (1983) 1982-1986
3. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., Palmiter R.D., and Brinster R.L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318 (1985) 533-538
4. Belotserkovskii B.P., De Silva E., Tornaletti S., Wang G., Vasquez K.M., and Hanawalt P.C. A triplex-forming sequence from the human c-MYC promoter interferes with DNA transcription. J. Biol. Chem. 282 (2007) 32433-32441
5. Boles T.C., and Hogan M.E. DNA structure equilibria in the human c-myc gene. Biochemistry 26 (1987) 367-376
6. Bransteitter R., Pham P., Scharff M.D., and Goodman M.F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA 100 (2003) 4102-4107
7. Burgess S.M., and Kleckner N. Collisions between yeast chromosomal loci in vivo are governed by three layers of organization. Genes Dev. 13 (1999) 1871-1883
8. Chakalova L., Carter D., and Fraser P. RNA fluorescence in situ hybridization tagging and recovery of associated proteins to analyze in vivo chromatin interactions. Methods Enzymol. 375 (2004) 479-493
9. Chaudhuri J., Tian M., Khuong C., Chua K., Pinaud E., and Alt F.W. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422 (2003) 726-730
10. Chaudhuri J., Basu U., Zarrin A., Yan C., Franco S., Perlot T., Vuong B., Wang J., Phan R.T., Datta A., et al. Evolution of the immunoglobulin heavy chain class switch recombination mechanism. Adv. Immunol. 94 (2007) 157-214
11. Cory S., Adams J.M., Gerondakis S.D., Miller J.F., Gamble J., Wiener F., Spira J., and Francke U. Fusion of DNA region to murine immunoglobulin heavy chain locus corresponds to plasmacytoma-associated chromosome translocation. EMBO J. 2 (1983) 213-216
12. Crews S., Barth R., Hood L., Prehn J., and Calame K. Mouse c-myc oncogene is located on chromosome 15 and translocated to chromosome 12 in plasmacytomas. Science 218 (1982) 1319-1321
13. Dalla-Favera R., Martinotti S., Gallo R.C., Erikson J., and Croce C.M. Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 219 (1983) 963-967
14. Davis A.C., Wims M., Spotts G.D., Hann S.R., and Bradley A. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7 (1993) 671-682
15. Di Noia J., and Neuberger M.S. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419 (2002) 43-48
16. Di Noia J.M., and Neuberger M.S. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 76 (2007) 1-22
17. Dickerson S.K., Market E., Besmer E., and Papavasiliou F.N. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 197 (2003) 1291-1296
18. Difilippantonio M.J., Zhu J., Chen H.T., Meffre E., Nussenzweig M.C., Max E.E., Ried T., and Nussenzweig A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404 (2000) 510-514
19. Dorsett Y., Robbiani D.F., Jankovic M., Reina-San-Martin B., Eisenreich T.R., and Nussenzweig M.C. A role for AID in chromosome translocations between c-myc and the IgH variable region. J. Exp. Med. 204 (2007) 2225-2232
20. Dorsett Y., McBride K.M., Jankovic M., Gazumyan A., Thai T.H., Robbiani D.F., Di Virgilio M., San-Martin B.R., Heidkamp G., Schwickert T.A., et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28 (2008) 630-638
21. Dudley D.D., Manis J.P., Zarrin A.A., Kaylor L., Tian M., and Alt F.W. Internal IgH class switch region deletions are position-independent and enhanced by AID expression. Proc. Natl. Acad. Sci. USA 99 (2002) 9984-9989
22. Egli D., Hafen E., and Schaffner W. An efficient method to generate chromosomal rearrangements by targeted DNA double-strand breaks in Drosophila melanogaster. Genome Res. 14 (2004) 1382-1393
23. Erikson J., ar-Rushdi A., Drwinga H.L., Nowell P.C., and Croce C.M. Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma. Proc. Natl. Acad. Sci. USA 80 (1983) 820-824
24. Franco S., Alt F.W., and Manis J.P. Pathways that suppress programmed DNA breaks from progressing to chromosomal breaks and translocations. DNA Repair (Amst.) 5 (2006) 1030-1041
25. Goossens T., Klein U., and Kuppers R. Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc. Natl. Acad. Sci. USA 95 (1998) 2463-2468
26. Gordon M.S., Kanegai C.M., Doerr J.R., and Wall R. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc. Natl. Acad. Sci. USA 100 (2003) 4126-4131
27. Gribnau J., de Boer E., Trimborn T., Wijgerde M., Milot E., Grosveld F., and Fraser P. Chromatin interaction mechanism of transcriptional control in vivo. EMBO J. 17 (1998) 6020-6027
28. Gribnau J., Diderich K., Pruzina S., Calzolari R., and Fraser P. Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus. Mol. Cell 5 (2000) 377-386
29. Hamlyn P.H., and Rabbitts T.H. Translocation joins c-myc and immunoglobulin gamma 1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene. Nature 304 (1983) 135-139
30. Imai K., Slupphaug G., Lee W.I., Revy P., Nonoyama S., Catalan N., Yel L., Forveille M., Kavli B., Krokan H.E., et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4 (2003) 1023-1028
31. Jankovic M., Nussenzweig A., and Nussenzweig M.C. Antigen receptor diversification and chromosome translocations. Nat. Immunol. 8 (2007) 801-808
32. Kovalchuk A.L., duBois W., Mushinski E., McNeil N.E., Hirt C., Qi C.F., Li Z., Janz S., Honjo T., Muramatsu M., et al. AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements. J. Exp. Med. 204 (2007) 2989-3001
33. Kuppers R., and Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20 (2001) 5580-5594
34. Leder P., Battey J., Lenoir G., Moulding C., Murphy W., Potter H., Stewart T., and Taub R. Translocations among antibody genes in human cancer. Science 222 (1983) 765-771
35. Lieber M.R., Ma Y., Pannicke U., and Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat. Rev. Mol. Cell Biol. 4 (2003) 712-720
36. Liu J., and Levens D. Making myc. Curr. Top. Microbiol. Immunol. 302 (2006) 1-32
37. Liu M., Duke J.L., Richter D.J., Vinuesa C.G., Goodnow C.C., Kleinstein S.H., and Schatz D.G. Two levels of protection for the B cell genome during somatic hypermutation. Nature 451 (2008) 841-845
38. Marcu K.B., Harris L.J., Stanton L.W., Erikson J., Watt R., and Croce C.M. Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia. Proc. Natl. Acad. Sci. USA 80 (1983) 519-523
39. Marcu K.B., Bossone S.A., and Patel A.J. myc function and regulation. Annu. Rev. Biochem. 61 (1992) 809-860
40. Michael N., Shen H.M., Longerich S., Kim N., Longacre A., and Storb U. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19 (2003) 235-242
41. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., and Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274 (1999) 18470-18476
42. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
43. Muschen M., Re D., Jungnickel B., Diehl V., Rajewsky K., and Kuppers R. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J. Exp. Med. 192 (2000) 1833-1840
44. Nagaoka H., Muramatsu M., Yamamura N., Kinoshita K., and Honjo T. Activation-induced deaminase (AID)-directed hypermutation in the immunoglobulin Smu region: implication of AID involvement in a common step of class switch recombination and somatic hypermutation. J. Exp. Med. 195 (2002) 529-534
45. Osborne C.S., Chakalova L., Mitchell J.A., Horton A., Wood A.L., Bolland D.J., Corcoran A.E., and Fraser P. Myc dynamically and preferentially relocates to a transcription factory occupied by Igh. PLoS Biol. 5 (2007) e192
46. Parada L.A., Sotiriou S., and Misteli T. Spatial genome organization. Exp. Cell Res. 296 (2004) 64-70
47. Pasqualucci L., Migliazza A., Fracchiolla N., William C., Neri A., Baldini L., Chaganti R.S., Klein U., Kuppers R., Rajewsky K., et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. USA 95 (1998) 11816-11821
48. Pasqualucci L., Neumeister P., Goossens T., Nanjangud G., Chaganti R.S., Kuppers R., and Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412 (2001) 341-346
49. Peled J.U., Kuang F.L., Iglesias-Ussel M.D., Roa S., Kalis S.L., Goodman M.F., and Scharff M.D. The Biochemistry of Somatic Hypermutation. Annu. Rev. Immunol. 26 (2008) 481-511
50. Petersen S., Casellas R., Reina-San-Martin B., Chen H.T., Difilippantonio M.J., Wilson P.C., Hanitsch L., Celeste A., Muramatsu M., Pilch D.R., et al. AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 414 (2001) 660-665
51. Petersen-Mahrt S.K., Harris R.S., and Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418 (2002) 99-103
52. Pham P., Bransteitter R., Petruska J., and Goodman M.F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424 (2003) 103-107
53. Potter M. Neoplastic development in plasma cells. Immunol. Rev. 194 (2003) 177-195
54. Rada C., Williams G.T., Nilsen H., Barnes D.E., Lindahl T., and Neuberger M.S. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12 (2002) 1748-1755
55. Ramiro A.R., Stavropoulos P., Jankovic M., and Nussenzweig M.C. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat. Immunol. 4 (2003) 452-456
56. Ramiro A.R., Jankovic M., Eisenreich T., Difilippantonio S., Chen-Kiang S., Muramatsu M., Honjo T., Nussenzweig A., and Nussenzweig M.C. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118 (2004) 431-438
57. Ramiro A.R., Jankovic M., Callen E., Difilippantonio S., Chen H.T., McBride K.M., Eisenreich T.R., Chen J., Dickins R.A., Lowe S.W., et al. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440 (2006) 105-109
58. Reddy M.C., and Vasquez K.M. Repair of genome destabilizing lesions. Radiat. Res. 164 (2005) 345-356
59. Reina-San-Martin B., Difilippantonio S., Hanitsch L., Masilamani R.F., Nussenzweig A., and Nussenzweig M.C. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J. Exp. Med. 197 (2003) 1767-1778
60. Reina-San-Martin B., Chen H.T., Nussenzweig A., and Nussenzweig M.C. ATM is required for efficient recombination between immunoglobulin switch regions. J. Exp. Med. 200 (2004) 1103-1110
61. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102 (2000) 565-575
62. Richardson C., and Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405 (2000) 697-700
63. Roix J.J., McQueen P.G., Munson P.J., Parada L.A., and Misteli T. Spatial proximity of translocation-prone gene loci in human lymphomas. Nat. Genet. 34 (2003) 287-291
64. Shen H.M., Peters A., Baron B., Zhu X., and Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280 (1998) 1750-1752
65. Spencer C.A., and Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56 (1991) 1-48
66. Stanton L.W., Watt R., and Marcu K.B. Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature 303 (1983) 401-406
67. Stavnezer J., Guikema J.E., and Schrader C.E. Mechanism and Regulation of Class Switch Recombination. Annu. Rev. Immunol. 26 (2008) 261-292
68. Stoddard B.L. Homing endonuclease structure and function. Q. Rev. Biophys. 38 (2005) 49-95
69. Takizawa M., Tolarova H., Li Z., Dubois W., Lim S., Callen E., Franco S., Mosaico M., Feigenbaum L., Alt F.W., et al. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J. Exp. Med. 205 (2008) 1949-1957
70. Taub R., Kirsch I., Morton C., Lenoir G., Swan D., Tronick S., Aaronson S., and Leder P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. USA 79 (1982) 7837-7841
71. Van Duyne G.D. A structural view of cre-loxp site-specific recombination. Annu. Rev. Biophys. Biomol. Struct. 30 (2001) 87-104
72. Wierstra I., and Alves J. The c-myc promoter: still MysterY and challenge. Adv. Cancer Res. 99 (2008) 113-333
73. Wilson P.C., de Bouteiller O., Liu Y.J., Potter K., Banchereau J., Capra J.D., and Pascual V. Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J. Exp. Med. 187 (1998) 59-70
74. Yang D., and Hurley L.H. Structure of the biologically relevant G-quadruplex in the c-MYC promoter. Nucleosides Nucleotides Nucleic Acids 25 (2006) 951-968
75. Yu K., Chedin F., Hsieh C.L., Wilson T.E., and Lieber M.R. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat. Immunol. 4 (2003) 442-451
76. Yu Y., and Bradley A. Engineering chromosomal rearrangements in mice. Nat. Rev. Genet. 2 (2001) 780-790
77. Zan H., Wu X., Komori A., Holloman W.K., and Casali P. AID-dependent generation of resected double-strand DNA breaks and recruitment of Rad52/Rad51 in somatic hypermutation. Immunity 18 (2003) 727-738